investors

PRESS RELEASES

Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
Angion to Present Multiple Posters at Kidney Week 2020
Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
Angion Initiates Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia
see more

EVENTS

Stay tuned for future events

CORPORATE PRESENTATION